IJCS | Volume 33, Nº3, May / June 2020

277 1. World Health Organization.WHO. A global brief on hypertension. Silent killer, global public health crisis. Geneva: World Health Organization; 2013. 2 Sabate E.Adherence to long term therapies. Evidence for action. Geneva: World Health Organization; 2003. 3. LawMR, Morris JK, WaldNJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009 May 19;338:b1665. 4. ManciaG, Fagard R, Narkiewicz K, Redon J, Zanchetti A, BohmM, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281-1357. 5. van Veen WA. Treatment adherence in hypertension: problems and research. J R Coll Gen Pract Occas Pap. 1980 Jul;(12):22-5. 6. Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013;62(2):218-25. 7. van der Laan DM, Elders PJM, Boons CCLM, Beckeringh JJ, Nijpels G, Hugtenburg JG. Factors associated with antihypertensive medication nonadherence: a systematic review. J HumHypertens. 2017;31(11):687-94. 8. Agbor VN, Essouma M, Ntusi NAB, Nyaga UF, Bigna JJ, Noubiap JJ. Heart failure in sub-Saharan Africa: a contemporaneous systematic review and meta-analysis. Int J Cardiol. 2018 Apr 15;257:207-15. 9. Nyaga UF, Bigna JJ, Agbor VN, Essouma M, Ntusi NAB, Noubiap JJ. Data on the epidemiology of heart failure in Sub-Saharan Africa. Data Brief. 2018 Apr;17:1218-39. 10. Vrijens B, De Geest S, Hughes DA, PrzemyslawK, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691-705. 11. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376, 162 patients. Am J Med. 2012;125(9):882-7. 12. Marin MJ, Fábregues G, Rodríguez PD, Díaz M, Paez O, Alfie J, et al. National Registry of Hypertension.Awareness, Treatment and Control of Hypertension. The RENATAStudy. Rev.Argent. Cardiol. 2012;80(2):121-8. 13. Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29(3):610-8. 14. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence for hypertension control. J Hypertens. 2008;10(5):348-54. 15. C Carbajal HA. Optimal blood pressure and high normal blood pressure in La Plata, Argentina. Can J Cardiol. 1994;10(7):749-52. 16. Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and Control of Hypertension: JACC Health Promotion Series. J Am Coll Cardiol. 2018;72(11):1278-93. 17. Hyre AD, Krousel-Wood MA, Muntner P, Kawasaki L, DeSalvo KB. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens. 2007;9(3):179-86. 18. Hamdidouche I, Jullien V, Boutouyrie P, Billaud E, Azizi M, Laurent S. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients. J Hypertens. 2017;35(9):1891-8. 19. Calderón-Larrañaga A, Diaz E, Poblador-Plou B, Gimeno-Feliu LA, Abad-Díez JM, Prados-Torres A. Non-adherence to antihypertensive medication: the role of mental and physical comorbidity. Int J Cardiol. 2016 Mar 15;207:310-16. 20. Gentil L, Vasiliadis HM, Preville M, Bossé C, Berbiche D. Association between depressive and anxiety disorders and adherence to antihypertensive medication in community-living elderly adults. J Am Geriatr Soc. 2012;60(12):2297-301. 21. Holt E, Joyce C, Dornelles A, Morisky D, Webber LS, Muntner P, et al. Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc. 2013;61(4):558-64. 22. Holt EW, Muntner P, Joyce CJ, Webber L, Krousel-Wood MA. Health- related quality of life and antihypertensive medication adherence among older adults. Age Ageing. 2010;39(4):481-7. 23. Ingaramo RA, Vita N, Bendersky M, Arnolt M, Bellindo C, Piscorz D, et al. Estudio Nacional Sobre Adherencia al Tratamiento (ENSAT).Rev Fed Arg Cardiol. 2005;34(1):104-11. References Espeche et al. Adherence to antihypertensive therapy in Argentina Int J Cardiovasc Sci. 2020; 33(3):272-277 Original Article This is an open-access article distributed under the terms of the Creative Commons Attribution License